[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200206196B - Pyrrolopyridazine compound. - Google Patents

Pyrrolopyridazine compound.

Info

Publication number
ZA200206196B
ZA200206196B ZA200206196A ZA200206196A ZA200206196B ZA 200206196 B ZA200206196 B ZA 200206196B ZA 200206196 A ZA200206196 A ZA 200206196A ZA 200206196 A ZA200206196 A ZA 200206196A ZA 200206196 B ZA200206196 B ZA 200206196B
Authority
ZA
South Africa
Prior art keywords
group
optionally substituted
medicament
cycloalkyl
pyrrolopyridazine
Prior art date
Application number
ZA200206196A
Other languages
English (en)
Inventor
Haruo Iwabuchi
Nobuhiko Shibakawa
Hiroshi Fujiwara
Masahiko Hagihara
Keiji Matsunobu
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of ZA200206196B publication Critical patent/ZA200206196B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA200206196A 2000-02-10 2002-08-02 Pyrrolopyridazine compound. ZA200206196B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000033627 2000-02-10

Publications (1)

Publication Number Publication Date
ZA200206196B true ZA200206196B (en) 2003-11-03

Family

ID=18558082

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206196A ZA200206196B (en) 2000-02-10 2002-08-02 Pyrrolopyridazine compound.

Country Status (21)

Country Link
US (1) US6734181B2 (xx)
EP (1) EP1254907B1 (xx)
KR (1) KR100750551B1 (xx)
CN (1) CN1285593C (xx)
AT (1) ATE361925T1 (xx)
AU (2) AU2001230585B2 (xx)
BR (1) BR0108251A (xx)
CA (1) CA2399380A1 (xx)
CZ (1) CZ20022742A3 (xx)
DE (1) DE60128329T2 (xx)
ES (1) ES2286094T3 (xx)
HK (1) HK1049163B (xx)
HU (1) HUP0204579A3 (xx)
IL (1) IL151167A0 (xx)
MX (1) MXPA02007799A (xx)
NO (1) NO20023771L (xx)
NZ (1) NZ520606A (xx)
PL (1) PL358014A1 (xx)
RU (1) RU2254335C2 (xx)
WO (1) WO2001058901A1 (xx)
ZA (1) ZA200206196B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418479A (en) * 2002-09-25 2004-10-01 Sankyo Co Pharmaceutical compositions for the treatment or prevention of visceral pains
WO2004029058A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 血中ガストリン濃度上昇の抑制のための医薬組成物
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
EP1787991B2 (en) * 2004-07-28 2020-06-24 Takeda Pharmaceutical Company Limited PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
KR100958828B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-b]피리딘 유도체 및 그의 제조방법
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97931A0 (en) 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
WO1992006979A1 (de) 1990-10-15 1992-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazine
WO1993008190A1 (de) * 1991-10-25 1993-04-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
ES2185693T3 (es) * 1994-01-19 2003-05-01 Sankyo Co Derivado de pirrolopiridacina.
JP3143571B2 (ja) * 1994-01-19 2001-03-07 三共株式会社 ピロロピリダジン誘導体
US5753664A (en) 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
JPH0995485A (ja) * 1995-03-16 1997-04-08 Takeda Chem Ind Ltd 複素環化合物、その製造法および剤
TWI287014B (en) 1999-06-15 2007-09-21 Sankyo Co Optically active pyrrolopyridazine compound

Also Published As

Publication number Publication date
CN1285593C (zh) 2006-11-22
NO20023771L (no) 2002-10-09
US6734181B2 (en) 2004-05-11
AU3058501A (en) 2001-08-20
HUP0204579A3 (en) 2006-01-30
EP1254907A1 (en) 2002-11-06
MXPA02007799A (es) 2002-10-17
AU2001230585B2 (en) 2005-01-06
KR100750551B1 (ko) 2007-08-20
RU2254335C2 (ru) 2005-06-20
RU2002121482A (ru) 2004-01-10
IL151167A0 (en) 2003-04-10
US20040014762A1 (en) 2004-01-22
WO2001058901A1 (fr) 2001-08-16
NO20023771D0 (no) 2002-08-09
HK1049163A1 (en) 2003-05-02
CA2399380A1 (en) 2001-08-16
KR20020072579A (ko) 2002-09-16
HK1049163B (zh) 2007-09-28
CN1422272A (zh) 2003-06-04
BR0108251A (pt) 2003-03-25
EP1254907B1 (en) 2007-05-09
CZ20022742A3 (cs) 2003-02-12
DE60128329T2 (de) 2008-01-10
PL358014A1 (en) 2004-08-09
NZ520606A (en) 2004-06-25
EP1254907A4 (en) 2004-11-24
DE60128329D1 (de) 2007-06-21
HUP0204579A2 (hu) 2003-04-28
ES2286094T3 (es) 2007-12-01
ATE361925T1 (de) 2007-06-15

Similar Documents

Publication Publication Date Title
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
WO2003049690A3 (en) Hiv integrase inhibitors
TW200745033A (en) Oxindole derivative as feeding control agent
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
HK1049163A1 (en) Pyrrolopyridazine compound
WO2006129168A3 (en) Bicyclic derivatives for the treatment of abnormal cell growth
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
NZ517315A (en) New derivatives of A-500359
ZA200110279B (en) Optically active pyrrolopyridazine compounds.
AP2001002314A0 (en) Substituted benzolactam compounds.
ATE266034T1 (de) Gastro-spezifische prodrugs
WO2005090320A3 (en) Triazole derivatives and method of using the same to treat hiv infections
HK1077070A1 (en) Oligosaccharide derivative
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.